NCT00290823View on ClinicalTrials.gov

Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Neurocysticercosis
Interventions
DRUG

Albendazole

400 mg tablet taken orally twice daily

DRUG

Dexamethasone

6mg or 8mg taken daily

DRUG

Omeprazole

20 mg tablet taken orally daily

Trial Locations (1)

Unknown

Instituto Especializado en Ciencias Neurologicas, Lima

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00290823 - Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients | Biotech Hunter | Biotech Hunter